Recombinant multi-species OPN1LW protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OPN1LW protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes for a light absorbing visual pigment of the opsin gene family. The encoded protein is called red cone photopigment or long-wavelength sensitive opsin. Opsins are G-protein coupled receptors with seven transmembrane domains, an N-terminal extracellular domain, and a C-terminal cytoplasmic domain. This gene and the medium-wavelength opsin gene are tandemly arrayed on the X chromosome and frequent unequal recombination and gene conversion may occur between these sequences. X chromosomes may have fusions of the medium- and long-wavelength opsin genes or may have more than one copy of these genes. Defects in this gene are the cause of partial, protanopic colorblindness. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CBBM,CBP,COD5,Long-wave-sensitive opsin 1,OPN1LW,RCP,ROP,Red cone photoreceptor pigment,Red-sensitive opsin (ROP)

Target products collectionGo to OPN1LW products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1304-Ag-1/ GM-Tg-hg-IP1304-Ag-2 Human OPN1LW protein Human
GM-Tg-rg-IP1304-Ag-1/ GM-Tg-rg-IP1304-Ag-2 Rat OPN1LW protein Rat
GM-Tg-mg-IP1304-Ag-1/ GM-Tg-mg-IP1304-Ag-2 Mouse OPN1LW protein Mouse
GM-Tg-cynog-IP1304-Ag-1/ GM-Tg-cynog-IP1304-Ag-2 Cynomolgus/Rhesus macaque OPN1LW protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1304-Ag-1/ GM-Tg-felg-IP1304-Ag-2 Feline OPN1LW protein Feline
GM-Tg-cang-IP1304-Ag-1/ GM-Tg-cang-IP1304-Ag-2 Canine OPN1LW protein Canine
GM-Tg-bovg-IP1304-Ag-1/ GM-Tg-bovg-IP1304-Ag-2 Bovine OPN1LW protein Bovine
GM-Tg-equg-IP1304-Ag-1/ GM-Tg-equg-IP1304-Ag-2 Equine OPN1LW protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1304-Ag-1/ GM-Tg-hg-IP1304-Ag-2; GM-Tg-rg-IP1304-Ag-1/ GM-Tg-rg-IP1304-Ag-2;
GM-Tg-mg-IP1304-Ag-1/ GM-Tg-mg-IP1304-Ag-2; GM-Tg-cynog-IP1304-Ag-1/ GM-Tg-cynog-IP1304-Ag-2;
GM-Tg-felg-IP1304-Ag-1/ GM-Tg-felg-IP1304-Ag-2; GM-Tg-cang-IP1304-Ag-1/ GM-Tg-cang-IP1304-Ag-2;
GM-Tg-bovg-IP1304-Ag-1/ GM-Tg-bovg-IP1304-Ag-2; GM-Tg-equg-IP1304-Ag-1/ GM-Tg-equg-IP1304-Ag-2
Products Name OPN1LW protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name OPN1LW
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OPN1LW protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.